Target intelligence / Profile preview

Pathogenic bacteria in upper respiratory tract

Molecular classification
Other
01

Overview

Pathogenic bacteria in the upper respiratory tract refers to several bacterial species capable of causing acute illnesses, including pharyngitis, sinusitis, otitis media, epiglottitis, and laryngotracheitis. Common pathogenic bacteria include Streptococcus pyogenes (primary cause of strep throat), Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Mycoplasma pneumoniae[1][2][3][4][6]. These organisms enter and colonize the mucosal surface of the respiratory tract, leading to a variety of symptoms due to inflammation, toxin production, and immune evasion. Diagnosis is typically confirmed by microbiological culture or rapid antigen testing. Treatment relies on antibiotics targeting bacterial cell wall or protein synthesis. Inappropriate antibiotic usage can encourage resistance and cause therapeutic complications, emphasizing the need for careful diagnosis and targeted intervention. This entry is not a valid single molecular target for drug development or biomarker usage.

Other names
Upper respiratory tract pathogensURT bacterial pathogensUpper respiratory tract bacteria
02

Mechanism of action

Inhibition of bacterial cell wall synthesis (by β-lactams); Inhibition of protein synthesis (by macrolides)

03

Biological functions

InfectionImmune evasionToxin production (as in diphtheria)Inflammation induction
04

Disease associations

Infection (pharyngitis, sinusitis, otitis media, epiglottitis, laryngotracheitis)
05

Safety considerations

Antibiotic resistance developmentAllergic reactions to antibioticsAdverse effects from inappropriate drug use (especially in children)
06

Interacting drugs

Penicillin antibiotics (e.g., amoxicillin, penicillin G)

2 more in the full profile.

07

Biomarkers

Throat swab culturesRapid antigen tests (group A Streptococcus)PCR detection of specific bacterial genes (e.g., diphtheria tox gene)

Beyond the preview

Go deeper on Pathogenic bacteria in upper respiratory tract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic bacteria in upper respiratory tract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call